Affinivax Inc logo
VerifiedBiotechnology Research

Affinivax Inc

Affinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees14(51 to 200)Annual revenue$10M to <$50MWebsitegsk.comLinkedIn profileLinkedIn

Verified contacts

10

available on Kipplo

LinkedIn employees

14

51 to 200 range

Open roles

no listings

Distinct roles

8

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 10 verified contacts at Affinivax Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

10 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Affinivax Inc

8 distinct titles indexed · top 8 shown.

  • 2associate director quality assurance
  • 1associate director, quality assurance validation
  • 1associate scientist
  • 1director
  • 1director, drug product formulation and process development
  • 1qc analyst 2
  • 1qc analyst ii
  • 1vice president

Sign up to unlock all 10 contacts at Affinivax Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 10 verified contacts at Affinivax Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Affinivax Inc | Kipplo Discover